Topic Archives: Frontline (FRO)

Comments

  • Avatar

    Thanks for an excellent summation on Alzheimer. It is better than most of the scientific papers in the medical communit...

  • Gr8Full!

    #EndPoints Early Edition NEW Novartis poaches Bristol-Myers/Amgen vet John Tsai for top drug development post in a ...

  • Dr. KSS MD PhD

    Thanks paul. I am predicting a positive read. I feel the supporting basic science is good and marches in tune to the cli...

  • Avatar

    $STML: New Cowan report (3/23) SUMMARY: STML announced that it has completed enrollment of SL-401's pivotal study in...

  • Dr. KSS MD PhD

    Competent, happy with a life doing public work, appropriate humility level, appropriate social graces, excellent underst...

  • Avatar

    Not dumb at all Lumpy. It's just an opinion I hold after all, I have no idea if the Doc agrees or not. I have always ...

  • Avatar

    A class action suit was filed against the company on Dec. 16, 2016, one in NY, one in the U.S. District Court for the So...

  • Avatar

    $TGTX: A great interview article relevant to Target Therapeutics, CLL and its competitive landscape From Targeted Onc...

  • Avatar

    Back to fleas for a moment, with apologies. I live between two golf courses, and there are families of red foxes at both...

  • Dr. KSS MD PhD

    When you have time I encourage everyone here to watch this PBS FRONTLINE documentary about the horrors of the supplemen...

  • Gui_

    FRONTLINE will continue their investigative series on herbal supplements Tuesday, January 19th 2016 10:00 P:M ET and Wed...

  • sogiam

    TRVN-Trevena Announces Presentations at PAINWeek(R) 2015 7:00 am ET September 8, 2015 (BusinessWire) Print Trevena, In...

  • Avatar

    There's a real need for Overdose Kits which opioid abusers and their friends could carry with them or keep nearby. Here ...

  • psvena

    I'm glad to see we are on the same page, Travis. In Dr. KSS's Frontline Dispatch from the Cholesterol Wars thread, post...

  • Avatar

    Dr. KSS, I just finished reading Frontline Dispatch . . .. Thank you for another great article, and thanks for ...

  • Dr. KSS, MD PhD

    Thanks Dan----let;s be honest: $MEIP could still go, as my friend Alan Rex says, tits up. AND SO COULD ANY OTHER BIOTECH...

  • Dr. KSS, MD PhD

    No reason to have a cow about $MEIP. Pracinostat as frontline for MDS wasn't something I was betting on. Will explain la...

  • Avatar

    Re: traumatic brain injury Decreased ability to identify specific odors can predict abnormal neuroimaging results in...

  • sogiam

    ATNM-Experts in Leukemia Treatment Support Ongoing Phase 1/2 Study of Actinium's Actimab-A, a Low Intensity Therapy for ...

  • Avatar

    Informational Frontline report on the Trouble with Anribiotics.Long in length but worth the watch. http://www.pbs.org/wg...

  • Avatar

    Dr KSS, :) I just fixed the abdomen with 101 stitches. Months ago I was reading up on Benitec and when Mr F...

  • jer_vic

    I deal with BMO InvestorLine. Their frontline telephone support was helpful, but not knowledgeable. I explained the si...

  • Avatar

    PBS' "Frontline" aired "Hunting the Nightmare Bacteria" last night. I am a fan of Frontline generally, but the program ...

  • Avatar

    Perhaps this is a different type of pump...... As I remember, Patrick Cox recently ish joined John Mauldin's Trans Tech ...

  • Avatar

    Well perhaps not this claim, but a number of others show he has the POTUS in his Change Purse. Perhaps you should watch...

  • Travis Johnson, Stock Gumshoe

    Lots of overcapacity in both bulker (golden ocean) and tanker businesses right now, from what I can tell -- and since Sh...

  • Avatar

    I've owned Golar since 2007 in my IRA, where it has doubled in that period. I am considering the MLP spinoff, large...

  • Avatar

    I reached basically the same conclusions on what stocks were being teased and that they are too expensive at this point ...

  • Avatar

    Excellent point, should have included his ownership above. Yes, I often find it helpful to follow big investors -- thou...

  • Avatar

    John Malden's Thoughts from the Frontline is the only view that I take totally seriously. I haven't seen a review of hi...

  • Avatar

    Human? I resemble that remark! Thanks David. I agree on Seadrill, but for Fredriksen followers you might note ...

  • Avatar

    I bought some Frontline last week BUT I also bought two puts to protect the position. The price went down and I sold 1 p...

  • Avatar

    I own a few shares of Frontline, do you think at todays prices it's worth buying somemore? The yield is looking too good...

  • Avatar

    Travis, Why not look at OSG. It owns and leases vessels, including several of SeaDrills rigs to SeaDrill, Frontline, e...

  • Avatar

    We've about bandied Frontline to death, elsewhere. And probably with good cause. Fredriksen feels that having the larg...

  • Avatar

    There are a lot of shipping fleets out there. The two I favor long term, are Frontline, and Torm. Frontline because it...

  • Avatar

    Mr. Nabloid, You're my kinda' investor... But;Don't give up on the Canadian Trusts just yet.. Most are working on the ...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch